Shopping Cart
- Remove All
- Your shopping cart is currently empty
GZD856 formic is a potent, orally active inhibitor of PDGFRα/β and Bcr-Abl T315I, demonstrating IC50 values of 68.6 nM and 136.6 nM for PDGFRα/β, respectively, and 19.9 nM and 15.4 nM for native Bcr-Abl and the T315I mutant, respectively. This compound exhibits significant antitumor activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $1,400 | 10-14 weeks | |
50 mg | $1,820 | 10-14 weeks |
Description | GZD856 formic is a potent, orally active inhibitor of PDGFRα/β and Bcr-Abl T315I, demonstrating IC50 values of 68.6 nM and 136.6 nM for PDGFRα/β, respectively, and 19.9 nM and 15.4 nM for native Bcr-Abl and the T315I mutant, respectively. This compound exhibits significant antitumor activity. |
Molecular Weight | 578.58 |
Formula | C30H29F3N6O3 |
Cas No. | 2804039-78-7 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.